EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities

Isadora Ritter Müller, Gabriel Linden, Mariele Feiffer Charão, Marina Venzon Antunes, Rafael Linden

Expert Review of Clinical Pharmacology · 03.08.2023 · 16 (8) · 691-701

DOI: 10.1080/17512433.2023.2224562 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 12.06.2023. Verfasst von Isadora Ritter Müller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical Toxicology, Universidade Feevale, Novo Hamburgo, Brazil. Hauptthemen laut MEDLINE: Drug Monitoring, Dried Blood Spot Testing. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The use of dried blood spots (DBS) has gained interest in the field of therapeutic drug monitoring (TDM) due to its potential advantages, such as minimally invasive capillary blood collection, potential stabilization of drugs and metabolites at room or high temperatures, and lower biohazard, allowing for inexpensive storage and transportation. However, there are several drawbacks to the clinical use of DBS in TDM, mostly related to hematocrit (Hct) effects, differences between venous and capillary blood concentrations, among others, that must be evaluated during analytical and clinical method validation. AREA COVERED: This review focuses on the most recent publications on the applications of DBS sampling for TDM (2016-2022), with a special focus on the challenges presented by this alternative sampling strategy, as well as the opportunities for clinical applications. Real-life studies presenting clinical applications were reviewed. EXPERT OPINION: With the availability of method development and validation guidelines for DBS-based methods in TDM, higher levels of assay validation standardization have been achieved, expanding the clinical applications of DBS sampling in patient care. New sampling devices that overcome the limitations of classical DBS, such as the Hct effects, will further encourage the use of DBS in routine TDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringDried Blood Spot TestingHumansHematocrit

Stichwörter der Autor:innen

Dried blood spotsalternative samplingcapillary sampling devicesmicrosamplingtherapeutic drug monitoring

Autor:innen und Institutionen

  • Laboratory of Analytical Toxicology, Universidade Feevale, Novo Hamburgo, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Müller, I. R., Linden, G., Charão, M. F., Antunes, M. V., & Linden, R. (2023). Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities. Expert Review of Clinical Pharmacology, 16(8), 691-701. https://doi.org/10.1080/17512433.2023.2224562

Vancouver

Müller IR, Linden G, Charão MF, Antunes MV, Linden R. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities. Expert Review of Clinical Pharmacology. 2023;16(8):691-701. doi:10.1080/17512433.2023.2224562

BibTeX
@article{Mller2023,
  author = {Müller, Isadora Ritter and Linden, Gabriel and Charão, Mariele Feiffer and Antunes, Marina Venzon and Linden, Rafael},
  title = {Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2023},
  volume = {16},
  number = {8},
  pages = {691--701},
  doi = {10.1080/17512433.2023.2224562}
}
Kostenlos starten →